TRDA
Entrada Therapeutics, Inc. · Healthcare
Chief Medical Officer Nerissa Kreher sold $70K of Entrada Therapeutics, Inc.
Sold$69,932
$13.45Price
5,200Shares
−25%Stake
What TRDA did after the filing
- The stock from Tue, Jan 3 close, $13.44
- −19.3%
- S&P 500, same days
- +8.7%
Measured over 30 trading days, to the Feb 15 close.
Traded Fri, Dec 30. Filed Tue, Jan 3, 11:32 AM ET, during the session. Returns use the Jan 3 close and the Feb 15 close. Not investment advice.